Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

Raj K. Gopal, Kirsten Kübler, Sarah E. Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M. Sadow, Braidie Campbell, Samuel E. Donovan, Salma Amin, Benjamin J. Gigliotti, Zenon Grabarek, Julian M. Hess, Chip Stewart, Lior Z. Braunstein, Peter F. Arndt, Scott Mordecai, Angela R. Shih, Frances Chaves, Tiannan ZhanCarrie C. Lubitz, Jiwoong Kim, A. John Iafrate, Lori Wirth, Sareh Parangi, Ignaty Leshchiner, Gilbert H. Daniels, Vamsi K. Mootha, Dora Dias-Santagata, Gad Getz, David G. McFadden

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hürthle cell carcinoma of the thyroid (HCC) is a form of thyroid cancer recalcitrant to radioiodine therapy that exhibits an accumulation of mitochondria. We performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter. Parallel analysis of mtDNA revealed recurrent homoplasmic mutations in subunits of complex I of the electron transport chain. Analysis of DNA copy-number alterations uncovered widespread loss of chromosomes culminating in near-haploid chromosomal content in a large fraction of HCC, which was maintained during metastatic spread. This work uncovers a distinct molecular origin of HCC compared with other thyroid malignancies. Gopal et al. identify recurrent alterations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter, as well as in mtDNA-encoding complex I of the electron transport chain, in Hürthle cell carcinomas (HCC). Many HCCs harbor widespread chromosomal loss culminating in a near-haploid state.

Original languageEnglish (US)
Pages (from-to)242-255.e5
JournalCancer Cell
Volume34
Issue number2
DOIs
StatePublished - Aug 13 2018

Fingerprint

Mitochondrial DNA
Thyroid Neoplasms
Carcinoma
Electron Transport Complex I
Haploidy
Exome
Mutation
Neoplasms
Thyroid Gland
Mitochondria
Chromosomes
DNA
Therapeutics

Keywords

  • chromosomal losses
  • complex I
  • haploid
  • Hürthle cell
  • loss of heterozygosity
  • metastasis
  • mitochondria
  • mtDNA
  • oncocytic
  • thyroid cancer

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. / Gopal, Raj K.; Kübler, Kirsten; Calvo, Sarah E.; Polak, Paz; Livitz, Dimitri; Rosebrock, Daniel; Sadow, Peter M.; Campbell, Braidie; Donovan, Samuel E.; Amin, Salma; Gigliotti, Benjamin J.; Grabarek, Zenon; Hess, Julian M.; Stewart, Chip; Braunstein, Lior Z.; Arndt, Peter F.; Mordecai, Scott; Shih, Angela R.; Chaves, Frances; Zhan, Tiannan; Lubitz, Carrie C.; Kim, Jiwoong; Iafrate, A. John; Wirth, Lori; Parangi, Sareh; Leshchiner, Ignaty; Daniels, Gilbert H.; Mootha, Vamsi K.; Dias-Santagata, Dora; Getz, Gad; McFadden, David G.

In: Cancer Cell, Vol. 34, No. 2, 13.08.2018, p. 242-255.e5.

Research output: Contribution to journalArticle

Gopal, RK, Kübler, K, Calvo, SE, Polak, P, Livitz, D, Rosebrock, D, Sadow, PM, Campbell, B, Donovan, SE, Amin, S, Gigliotti, BJ, Grabarek, Z, Hess, JM, Stewart, C, Braunstein, LZ, Arndt, PF, Mordecai, S, Shih, AR, Chaves, F, Zhan, T, Lubitz, CC, Kim, J, Iafrate, AJ, Wirth, L, Parangi, S, Leshchiner, I, Daniels, GH, Mootha, VK, Dias-Santagata, D, Getz, G & McFadden, DG 2018, 'Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma', Cancer Cell, vol. 34, no. 2, pp. 242-255.e5. https://doi.org/10.1016/j.ccell.2018.06.013
Gopal, Raj K. ; Kübler, Kirsten ; Calvo, Sarah E. ; Polak, Paz ; Livitz, Dimitri ; Rosebrock, Daniel ; Sadow, Peter M. ; Campbell, Braidie ; Donovan, Samuel E. ; Amin, Salma ; Gigliotti, Benjamin J. ; Grabarek, Zenon ; Hess, Julian M. ; Stewart, Chip ; Braunstein, Lior Z. ; Arndt, Peter F. ; Mordecai, Scott ; Shih, Angela R. ; Chaves, Frances ; Zhan, Tiannan ; Lubitz, Carrie C. ; Kim, Jiwoong ; Iafrate, A. John ; Wirth, Lori ; Parangi, Sareh ; Leshchiner, Ignaty ; Daniels, Gilbert H. ; Mootha, Vamsi K. ; Dias-Santagata, Dora ; Getz, Gad ; McFadden, David G. / Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. In: Cancer Cell. 2018 ; Vol. 34, No. 2. pp. 242-255.e5.
@article{1e086bcc7e11447f87a8c4a525dfc0cb,
title = "Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in H{\"u}rthle Cell Carcinoma",
abstract = "H{\"u}rthle cell carcinoma of the thyroid (HCC) is a form of thyroid cancer recalcitrant to radioiodine therapy that exhibits an accumulation of mitochondria. We performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter. Parallel analysis of mtDNA revealed recurrent homoplasmic mutations in subunits of complex I of the electron transport chain. Analysis of DNA copy-number alterations uncovered widespread loss of chromosomes culminating in near-haploid chromosomal content in a large fraction of HCC, which was maintained during metastatic spread. This work uncovers a distinct molecular origin of HCC compared with other thyroid malignancies. Gopal et al. identify recurrent alterations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter, as well as in mtDNA-encoding complex I of the electron transport chain, in H{\"u}rthle cell carcinomas (HCC). Many HCCs harbor widespread chromosomal loss culminating in a near-haploid state.",
keywords = "chromosomal losses, complex I, haploid, H{\"u}rthle cell, loss of heterozygosity, metastasis, mitochondria, mtDNA, oncocytic, thyroid cancer",
author = "Gopal, {Raj K.} and Kirsten K{\"u}bler and Calvo, {Sarah E.} and Paz Polak and Dimitri Livitz and Daniel Rosebrock and Sadow, {Peter M.} and Braidie Campbell and Donovan, {Samuel E.} and Salma Amin and Gigliotti, {Benjamin J.} and Zenon Grabarek and Hess, {Julian M.} and Chip Stewart and Braunstein, {Lior Z.} and Arndt, {Peter F.} and Scott Mordecai and Shih, {Angela R.} and Frances Chaves and Tiannan Zhan and Lubitz, {Carrie C.} and Jiwoong Kim and Iafrate, {A. John} and Lori Wirth and Sareh Parangi and Ignaty Leshchiner and Daniels, {Gilbert H.} and Mootha, {Vamsi K.} and Dora Dias-Santagata and Gad Getz and McFadden, {David G.}",
year = "2018",
month = "8",
day = "13",
doi = "10.1016/j.ccell.2018.06.013",
language = "English (US)",
volume = "34",
pages = "242--255.e5",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

AU - Gopal, Raj K.

AU - Kübler, Kirsten

AU - Calvo, Sarah E.

AU - Polak, Paz

AU - Livitz, Dimitri

AU - Rosebrock, Daniel

AU - Sadow, Peter M.

AU - Campbell, Braidie

AU - Donovan, Samuel E.

AU - Amin, Salma

AU - Gigliotti, Benjamin J.

AU - Grabarek, Zenon

AU - Hess, Julian M.

AU - Stewart, Chip

AU - Braunstein, Lior Z.

AU - Arndt, Peter F.

AU - Mordecai, Scott

AU - Shih, Angela R.

AU - Chaves, Frances

AU - Zhan, Tiannan

AU - Lubitz, Carrie C.

AU - Kim, Jiwoong

AU - Iafrate, A. John

AU - Wirth, Lori

AU - Parangi, Sareh

AU - Leshchiner, Ignaty

AU - Daniels, Gilbert H.

AU - Mootha, Vamsi K.

AU - Dias-Santagata, Dora

AU - Getz, Gad

AU - McFadden, David G.

PY - 2018/8/13

Y1 - 2018/8/13

N2 - Hürthle cell carcinoma of the thyroid (HCC) is a form of thyroid cancer recalcitrant to radioiodine therapy that exhibits an accumulation of mitochondria. We performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter. Parallel analysis of mtDNA revealed recurrent homoplasmic mutations in subunits of complex I of the electron transport chain. Analysis of DNA copy-number alterations uncovered widespread loss of chromosomes culminating in near-haploid chromosomal content in a large fraction of HCC, which was maintained during metastatic spread. This work uncovers a distinct molecular origin of HCC compared with other thyroid malignancies. Gopal et al. identify recurrent alterations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter, as well as in mtDNA-encoding complex I of the electron transport chain, in Hürthle cell carcinomas (HCC). Many HCCs harbor widespread chromosomal loss culminating in a near-haploid state.

AB - Hürthle cell carcinoma of the thyroid (HCC) is a form of thyroid cancer recalcitrant to radioiodine therapy that exhibits an accumulation of mitochondria. We performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter. Parallel analysis of mtDNA revealed recurrent homoplasmic mutations in subunits of complex I of the electron transport chain. Analysis of DNA copy-number alterations uncovered widespread loss of chromosomes culminating in near-haploid chromosomal content in a large fraction of HCC, which was maintained during metastatic spread. This work uncovers a distinct molecular origin of HCC compared with other thyroid malignancies. Gopal et al. identify recurrent alterations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter, as well as in mtDNA-encoding complex I of the electron transport chain, in Hürthle cell carcinomas (HCC). Many HCCs harbor widespread chromosomal loss culminating in a near-haploid state.

KW - chromosomal losses

KW - complex I

KW - haploid

KW - Hürthle cell

KW - loss of heterozygosity

KW - metastasis

KW - mitochondria

KW - mtDNA

KW - oncocytic

KW - thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=85049891350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049891350&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2018.06.013

DO - 10.1016/j.ccell.2018.06.013

M3 - Article

C2 - 30107175

AN - SCOPUS:85049891350

VL - 34

SP - 242-255.e5

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -